Inventor · disambiguated record
Rogelio L. Martinez
Also filed as: MARTINEZ ROGELIO · MARTINEZ ROGELIO L
7 granted patents·7 pending applications·60 citations·filing 2002–2024
83Inventor score
Files withBRISTOL MYERS SQUIBB CO6UNIV TEMPLE3SHIFA BIOMEDICAL CORP2HUNT JULIANNE A1TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION1
Top patents by PatentIndex Score
14 records- 0191US8436028B2CETP inhibitors derived from benzoxazole arylamidesHUNT JULIANNE A·Filed 2008·Granted May 7, 2013·18 cites·18 claims
- 0291US7417028B2Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditionsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 26, 2008·20 cites·22 claims
- 0390US10131637B2Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2014·Granted Nov 20, 2018·10 cites·6 claims
- 0486US7534763B2Sustained release GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 19, 2009·5 cites·25 claims
- 0581US7655688B2Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 2, 2010·5 cites·8 claims
- 0680US2024246904A1Functionalized n,n-dialkylamino phenyl ethers and their method of useUNIV TEMPLE·Filed 2024·Application pending·0 cites
- 0770US9975879B2Beta lactams as modulators of glutamate uptake and methods for use thereofUNIV TEMPLE·Filed 2014·Granted May 22, 2018·2 cites·9 claims
- 0860US11873267B2Functionalized N,N-dialkylamino phenyl ethers and their method of useUNIV TEMPLE·Filed 2017·Granted Jan 16, 2024·0 cites·13 claims
- 0956US2008242593A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditionsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 1055US2018079730A1Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2017·Application pending·0 cites
- 1151US2010022457A1Sustained release glp-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 1246US2016257672A1Functionalized furan-2-sulfonamides exhibiting endothelial lipase inhibitionTEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2014·Application pending·0 cites
- 1346US2004087548A1Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionFiled 2002·Application pending·0 cites
- 1445US2007238669A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes related conditionsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →